TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Pathway Genomics Stock

Pathway Genomics Stock

pathway.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $127.23MM

Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.

Learn more about Pathway Genomics IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Pathway Genomics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Pathway Genomics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pathway Genomics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Pathway Genomics investors also invested in these private companies

International Business Machines

Team

Management Team

Kamal Adawi
CFO
K'Lene Oen
Chief Business Officer
Nilesh Dharajiya MD
Chief Laboratory Officer & Medical Director
James Plante
Founder, Board Member, CEO
Glenn Braunstein MD
Chief Medical Officer
Anja Kammesheidt Ph.D
Chief Scientific Officer
Michael Nova Ph.D
Chief Innovation Officer

Board Members

Christopher Kitching
Mark Sopp
Pathway Genomics
Peter Leddy Ph.D
Peter Pace

Other companies like Pathway Genomics in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

Tokens Journal 11/11/2018
Prostate Biopsy Market Size, Application,Revenue, Types, Trends in Future, Scope to 2021 - TokensJournal
The Prostate Biopsy Market  report  provides valuable and unique information which is very  essential. Further it also covers key players,application and future market condition.This information is extremely useful information for new and growing  company to mark themself over the market Prostate Biopsy market to grow at a CAGR OF 12.66% during the period 2017-2021. This …
Tokens Journal 11/11/2018
Direct-To-Consumer Genetic Testing Market with top 20 Countries data Forecast to 2022 with Global Key Companies Profile, Supply, Demand, Cost Structure and Growth Factors - TokensJournal
Direct-To-Consumer Genetic Testing Market Report cover detailed competitive outlook including the Direct-To-Consumer Genetic Testing Industry share and company profiles of the key participants operating in the global market. The Direct-To-Consumer Genetic Testing market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and …
Bitnews Today 10/27/2018
Direct-to-consumer Genetic Testing Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2023 - BitsEther
Direct-to-consumer Genetic Testing Market Research highlights key dynamics of Global Direct-to-consumer Genetic Testing Industry sector. The potential of the Direct-to-consumer Genetic Testing Market has been investigated along with the key challenges. The current Direct-to-consumer Genetic Testing Market scenario and future prospects of the sector has also been studied. Market Report provides additional information like Sales Channel, Distributors, Traders …

Trending Companies

Frequently Asked Questions

Updated on: Apr 24, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.